This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Higuchi, H. Articles by Gores, G. J. Search for Related Content PubMed PubMed Citation Articles by Higuchi, H. Articles by Gores, G. J.

Viral Fusogenic Membrane Glycoprotein Expression Causes Syncytia Formation with Bioenergetic Cell Death: Implications for Gene Therapy¹

Center for Basic Research in Digestive Diseases [H. H., S. F. B., G. J. G.], Molecular Medicine Program [A. B., K. H., R. G. V.], Mayo Clinic, Rochester Minnesota 55905

Viral fusogenic membrane glycoproteins (FMGs) are candidates for gene therapy of solid tumors because they cause cell fusion, leading to formation of lethal multinucleated syncytia. However, the cellular mechanisms mediating cell death after FMG-induced cell fusion remain unclear. The present study was designed to examine the mechanisms by which FMG expression in hepatocellular carcinoma cells lead to cell death. Transfection of Hep3B cells with the Gibbon Ape leukemia virus hyperfusogenic envelope protein (GALV-FMG) resulted in the formation of multinucleated syncytia that reached a maximum 5 days after transfection (100 nuclei/syncytia). The syncytia were viable for a period of 2 days and then rapidly lost viability by day 5. Mitochondrial dysfunction occurred in GALV-FMG-induced syncytia prior to loss of viability with loss of the mitochondrial membrane potential, cellular ATP depletion, and release of mitochondrial cytochrome c-GFP into the cytosol. The pan-caspase inhibitor, Z-VAD-fmk, did not prevent cell death. However, glycolytic generation of ATP with fructose effectively increased cellular ATP and preserved syncytial viability. These data suggest that expression of FMG in hepatoma cells results in the formation of multinucleated syncytia, causing mitochondrial failure with ATP depletion, a bioenergetic form of cell death with necrosis. This form of cell death should be effective in vivo and enhance the bystander effect, suggesting that FMG-based gene therapy deserves further study for the treatment of hepatocellular and other cancers.

This article has been cited by other articles:

				M. D. Gainey, M. J. Manuse, and G. D. Parks A Hyperfusogenic F Protein Enhances the Oncolytic Potency of a Paramyxovirus Simian Virus 5 P/V Mutant without Compromising Sensitivity to Type I Interferon J. Virol., October 1, 2008; 82(19): 9369 - 9380. [Abstract] [Full Text] [PDF]

				T. Kottke, L. Sanchez-Perez, R. M. Diaz, J. Thompson, H. Chong, K. Harrington, S. K. Calderwood, J. Pulido, N. Georgopoulos, P. Selby, et al. Induction of hsp70-Mediated Th17 Autoimmunity Can Be Exploited as Immunotherapy for Metastatic Prostate Cancer Cancer Res., December 15, 2007; 67(24): 11970 - 11979. [Abstract] [Full Text] [PDF]

				D. Hoffmann and O. Wildner Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy. Mol. Cancer Ther., August 1, 2006; 5(8): 2013 - 2022. [Abstract] [Full Text] [PDF]

				X. Fu, L. Tao, M. Li, W. E. Fisher, and X. Zhang Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus. Clin. Cancer Res., May 15, 2006; 12(10): 3152 - 3157. [Abstract] [Full Text] [PDF]

				F. Errington, A. Bateman, T. Kottke, J. Thompson, K. Harrington, A. Merrick, P. Hatfield, P. Selby, R. Vile, and A. Melcher Allogeneic Tumor Cells Expressing Fusogenic Membrane Glycoproteins as a Platform for Clinical Cancer Immunotherapy Clin. Cancer Res., February 15, 2006; 12(4): 1333 - 1341. [Abstract] [Full Text] [PDF]

				J. Salsman, D. Top, J. Boutilier, and R. Duncan Extensive Syncytium Formation Mediated by the Reovirus FAST Proteins Triggers Apoptosis-Induced Membrane Instability J. Virol., July 1, 2005; 79(13): 8090 - 8100. [Abstract] [Full Text] [PDF]

				G. P. Horn, S. Vongpunsawad, E. Kornmann, B. Fritz, D. P. Dittmer, R. Cattaneo, and M. Dobbelstein Enhanced Cytotoxicity without Internuclear Spread of Adenovirus upon Cell Fusion by Measles Virus Glycoproteins J. Virol., February 1, 2005; 79(3): 1911 - 1917. [Abstract] [Full Text] [PDF]

				C. Chang, P.-T. Chen, G.-D. Chang, C.-J. Huang, and H. Chen Functional Characterization of the Placental Fusogenic Membrane Protein Syncytin Biol Reprod, December 1, 2004; 71(6): 1956 - 1962. [Abstract] [Full Text] [PDF]

				A.J.G. Potgens, S. Drewlo, M. Kokozidou, and P. Kaufmann Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action Hum. Reprod. Update, November 1, 2004; 10(6): 487 - 496. [Abstract] [Full Text] [PDF]

				N. W. Werneburg, J.-H. Yoon, H. Higuchi, and G. J. Gores Bile acids activate EGF receptor via a TGF-{alpha}-dependent mechanism in human cholangiocyte cell lines Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G31 - G36. [Abstract] [Full Text] [PDF]

				A. R. Bateman, K. J. Harrington, T. Kottke, A. Ahmed, A. A. Melcher, M. J. Gough, E. Linardakis, D. Riddle, A. Dietz, C. M. Lohse, et al. Viral Fusogenic Membrane Glycoproteins Kill Solid Tumor Cells by Nonapoptotic Mechanisms That Promote Cross Presentation of Tumor Antigens by Dendritic Cells Cancer Res., November 15, 2002; 62(22): 6566 - 6578. [Abstract] [Full Text] [PDF]

				E. Linardakis, A. Bateman, V. Phan, A. Ahmed, M. Gough, K. Olivier, R. Kennedy, F. Errington, K. J. Harrington, A. Melcher, et al. Enhancing the Efficacy of a Weak Allogeneic Melanoma Vaccine by Viral Fusogenic Membrane Glycoprotein-mediated Tumor Cell-Tumor Cell Fusion Cancer Res., October 1, 2002; 62(19): 5495 - 5504. [Abstract] [Full Text] [PDF]

				X. Fu and X. Zhang Potent Systemic Antitumor Activity from an Oncolytic Herpes Simplex Virus of Syncytial Phenotype Cancer Res., April 1, 2002; 62(8): 2306 - 2312. [Abstract] [Full Text] [PDF]

				H. Higuchi, H. Miyoshi, S. F. Bronk, H. Zhang, N. Dean, and G. J. Gores Bid Antisense Attenuates Bile Acid-Induced Apoptosis and Cholestatic Liver Injury J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 866 - 873. [Abstract] [Full Text] [PDF]